← SynDRA
MOLINDONE
SynDRA canonical compound SYN0000264 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- HTR2A
- HRH1
- ADRA1A
- Drd2
- Htr2a
- HTR7
- HTR6
- HTR2C
- HTR1A
- Drd1
- ADRA2A
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- DRD2 ANTAGONIST
- Dopamine D2 receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- HRH1 ANTAGONIST
- DRD2 BINDER
Drug classes
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Psychotropic Drugs
- Tranquilizing Agents
- Typical Antipsychotic
ATC classes
Cross-references
Synonyms
- (+/-)-Molindone
- molindone hydrochloride
- moban
- molindone HCl
- molindone monohydrochloride
- Molindona
- Spn-810
- SPN-810
- Molindone hydrochloride
- Molindone HCl
- Lidone
- Molindone (hydrochloride)
- EN-1733A
- EN 1733 A
- EN300-51039
- 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one hydrochloride
- Indol-4(5H)-one, 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-, monohydrochloride
- DSSTox_RID_80866
- DSSTox_CID_25417
- DSSTox_GSID_45417
- 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one hydrochloride
- SMR000499578
- 3-Ethyl-6,7-dihydro-2-methyl-5-morpholinomethylindo
- Molindonum
- Molindone Monohydrochloride
- Molindona [INN-Spanish]
- Molindone (INN)
- Molindone (MOL)
- Molindone [INN:BAN]
- Molindonum [INN-Latin]
- (+-)-Molindone
- 3-Ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-4H-indol-4-one
- 3-Ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)indol-4(5H)-one
- 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydro-4H-indol-4-one
- 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one
- 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-4,5,6,7-tetrahydro-1H-indol-4-one
- RT3Y3QMF8N
- RefChem:56582
Reported adverse events
- Akathisia
- Akinesia
- Dyskinesia
- Dystonia
- Tardive dyskinesia
- Urinary retention
Look up MOLINDONE in the interactive SynDRA portal →